Alpha Windward’s Bio-Rad Laboratories Class A BIO Stock Holding History

Alpha Windward’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-21	Closed	-$11K	–	46
2020 Q3	$11K	Sell	21 -14	-40%	-$7.09K	0.01%	341
2020 Q2	$16K	Buy	+35	New	+$15.4K	0.01%	335
2018 Q4	–	Sell	-108	Closed	-$34K	–	399
2018 Q3	$34K	Hold	108	–	–	0.02%	335
2018 Q2	$31K	Buy	+108	New	+$29.8K	0.02%	338
2017 Q2	–	Sell	-53	Closed	-$11K	–	415
2017 Q1	$11K	Hold	53	–	–	0.01%	390
2016 Q4	$10K	Sell	53 -4	-7%	-$682	0.01%	380
2016 Q3	$9K	Hold	57	–	–	0.01%	394
2016 Q2	$8K	Buy	57 +1	+2%	+$143	0.01%	384
2016 Q1	$8K	Hold	56	–	–	0.01%	390
2015 Q4	$8K	Sell	56 -156	-74%	-$21.6K	0.01%	380
2015 Q3	$28K	Hold	212	–	–	0.02%	349
2015 Q2	$32K	Buy	+212	New	+$30.3K	0.02%	327
2014 Q2	–	Sell	-248	Closed	-$32K	–	398
2014 Q1	$32K	Hold	248	–	–	0.02%	308
2013 Q4	$31K	Buy	248 +37	+18%	+$4.51K	0.02%	309
2013 Q3	$25K	Hold	211	–	–	0.02%	317
2013 Q2	$24K	Buy	+211	New	+$24.8K	0.02%	315

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Alpha Windward's BIO Position: Q4 2020 in Review

Alpha Windward sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2020, closing a stake of 21 shares — an estimated $11K sold.

Alpha Windward first reported a position in BIO in Q2 2013 and held it in 16 quarters. The position peaked at $34K in Q3 2018. 490 funds tracked by Wall St. Rank hold BIO as of Q4 2020.

Alpha Windward reported no remaining Bio-Rad Laboratories Class A position as of Q4 2020 after selling out during the quarter.
Alpha Windward sold 21 Bio-Rad Laboratories Class A shares in Q4 2020, an estimated $11K.
Alpha Windward first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and held it in 16 quarters.
Alpha Windward's Bio-Rad Laboratories Class A position peaked at $34K in Q3 2018.
490 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2020.

Based on Alpha Windward's 13F filing for Q4 2020.